TW201334779A - 糖尿病的治療藥 - Google Patents
糖尿病的治療藥 Download PDFInfo
- Publication number
- TW201334779A TW201334779A TW102102886A TW102102886A TW201334779A TW 201334779 A TW201334779 A TW 201334779A TW 102102886 A TW102102886 A TW 102102886A TW 102102886 A TW102102886 A TW 102102886A TW 201334779 A TW201334779 A TW 201334779A
- Authority
- TW
- Taiwan
- Prior art keywords
- group
- therapeutic
- prophylactic agent
- diabetes
- glucose metabolism
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012015351 | 2012-01-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW201334779A true TW201334779A (zh) | 2013-09-01 |
Family
ID=48873581
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW102102886A TW201334779A (zh) | 2012-01-27 | 2013-01-25 | 糖尿病的治療藥 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20150005506A1 (show.php) |
| EP (1) | EP2808018B1 (show.php) |
| JP (1) | JP5924699B2 (show.php) |
| KR (1) | KR20140134266A (show.php) |
| CN (1) | CN104066430A (show.php) |
| AR (1) | AR089812A1 (show.php) |
| AU (1) | AU2013212865A1 (show.php) |
| BR (1) | BR112014017902A2 (show.php) |
| CA (1) | CA2862602A1 (show.php) |
| HK (1) | HK1201209A1 (show.php) |
| IN (1) | IN2014DN05972A (show.php) |
| MX (1) | MX2014008484A (show.php) |
| RU (1) | RU2014134845A (show.php) |
| TW (1) | TW201334779A (show.php) |
| WO (1) | WO2013111870A1 (show.php) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104628672A (zh) * | 2015-02-10 | 2015-05-20 | 佛山市赛维斯医药科技有限公司 | 一类含苯基脒结构的烷氧苯基噻唑羧酸酰胺类化合物及用途 |
| CN104628673A (zh) * | 2015-02-10 | 2015-05-20 | 佛山市赛维斯医药科技有限公司 | 一类含叔丁基脒结构的腈基苯噻唑羧酸酰胺类化合物及用途 |
| CN104628671B (zh) * | 2015-02-10 | 2016-04-13 | 佛山市赛维斯医药科技有限公司 | 含苯基脒结构的硝基苯噻唑羧酸酰胺类化合物及用途 |
| CN104610190B (zh) * | 2015-02-10 | 2016-08-17 | 佛山市赛维斯医药科技有限公司 | 一类含环丙基脒结构的卤代苯基噻唑羧酸酰胺类化合物及用途 |
| CN104610188B (zh) * | 2015-02-10 | 2016-07-27 | 佛山市赛维斯医药科技有限公司 | 含苯基脒结构的腈基苯噻唑羧酸酰胺类化合物、其制备及用途 |
| KR102473677B1 (ko) * | 2015-08-17 | 2022-12-02 | 삼성디스플레이 주식회사 | 액정 표시 장치 |
| AR107661A1 (es) | 2016-02-19 | 2018-05-23 | Nat Univ Corp Tottori Univ | Agente terapéutico o profiláctico para la demencia |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU218942B (hu) | 1990-11-30 | 2001-01-29 | Teijin Ltd. | 2-Fenil-tiazol-származékok, az ezeket tartalmazó gyógyászati készítmények, valamint eljárás a vegyületek előállítására |
| HUP9902721A2 (hu) * | 1997-11-25 | 1999-12-28 | The Procter & Gamble Co. | Tömény textillágyító készítmény és ehhez alkalmazható magas telítetlenségű textillágyító vegyület |
| US20050074442A1 (en) * | 2002-03-13 | 2005-04-07 | Natarajan Ranganathan | Compositions and methods for augmenting kidney function |
| WO2006012438A2 (en) * | 2004-07-21 | 2006-02-02 | University Of Florida Research Foundation, Inc. | Compositions and methods for treatment and prevention of insulin resistance |
| CA2617161A1 (en) * | 2005-07-21 | 2007-02-15 | University Of Florida Research Foundation, Inc. | Compositions and methods for treatment and prevention of hyperuricemia related health consequences |
| WO2007019153A2 (en) | 2005-08-03 | 2007-02-15 | Tap Pharmaceutical Products, Inc. | Methods for treating hypertension |
| EP1957064A4 (en) * | 2005-11-21 | 2010-01-06 | Tap Pharmaceutical Prod Inc | TREATMENT OF QT INTERVAL EXTENSION AND RELEVANT DISEASES |
| JP2007210978A (ja) * | 2006-02-13 | 2007-08-23 | Hiroshima Univ | 耐糖能障害、ｉｉ型糖尿病、高脂血症、メタボリックシンドローム、内臓脂肪型肥満、脂肪肝または非アルコール性脂肪性肝炎の予防・治療剤 |
| JP2010509372A (ja) | 2006-11-13 | 2010-03-25 | タケダ・フアーマシユーテイカルズ・ノース・アメリカ・インコーポレイテツド | キサンチン酸化還元酵素阻害剤を使用する腎機能保持方法 |
| NZ595035A (en) * | 2007-11-27 | 2012-11-30 | Ardea Biosciences Inc | Substituted diazole and triazole compounds and compositions and methods of use |
| MY155517A (en) * | 2008-03-31 | 2015-10-30 | C&C Res Lab | Heterocyclic derivatives |
| WO2009134995A2 (en) * | 2008-04-30 | 2009-11-05 | Wellstat Therapeutics Corporation | Tetrazole compounds for reducing uric acid |
| EP2668953A1 (en) * | 2008-05-22 | 2013-12-04 | Bristol-Myers Squibb Company | Pharmaceutical compositions comprising an SGLT2 inhibitor with a supply of carbohydrate and/or an inhibitor of uric acid synthesis |
| WO2010045636A1 (en) * | 2008-10-19 | 2010-04-22 | Johnson Richard J | Therapeutic compositions and methods for treating chronic kidney disease associated with a metabolic imbalance |
| EP2470268A4 (en) * | 2009-08-24 | 2012-12-26 | Wound Man Pty Ltd | PURING-ORIENTED DIAGNOSIS AND THERAPY OF WOUNDS |
| JO3450B1 (ar) * | 2010-06-16 | 2020-07-05 | Takeda Pharmaceuticals Usa Inc | أشكال جرعات تحرير جديدة معدلة لمثبطات زانثين اوكسيدوريدوكتيز أو مثبطات زانثين اوكسيديز |
| WO2011162390A1 (ja) * | 2010-06-25 | 2011-12-29 | 帝人ファーマ株式会社 | 徐放性高血圧および腎機能障害治療剤 |
-
2013
- 2013-01-25 BR BR112014017902A patent/BR112014017902A2/pt not_active IP Right Cessation
- 2013-01-25 KR KR1020147020342A patent/KR20140134266A/ko not_active Withdrawn
- 2013-01-25 EP EP13740913.2A patent/EP2808018B1/en not_active Not-in-force
- 2013-01-25 AR ARP130100233A patent/AR089812A1/es unknown
- 2013-01-25 AU AU2013212865A patent/AU2013212865A1/en not_active Abandoned
- 2013-01-25 JP JP2013555326A patent/JP5924699B2/ja not_active Expired - Fee Related
- 2013-01-25 CN CN201380006730.6A patent/CN104066430A/zh active Pending
- 2013-01-25 MX MX2014008484A patent/MX2014008484A/es unknown
- 2013-01-25 WO PCT/JP2013/051627 patent/WO2013111870A1/ja not_active Ceased
- 2013-01-25 HK HK15101890.2A patent/HK1201209A1/xx unknown
- 2013-01-25 TW TW102102886A patent/TW201334779A/zh unknown
- 2013-01-25 IN IN5972DEN2014 patent/IN2014DN05972A/en unknown
- 2013-01-25 RU RU2014134845A patent/RU2014134845A/ru not_active Application Discontinuation
- 2013-01-25 CA CA2862602A patent/CA2862602A1/en not_active Abandoned
- 2013-01-25 US US14/372,961 patent/US20150005506A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013212865A1 (en) | 2014-08-14 |
| WO2013111870A1 (ja) | 2013-08-01 |
| EP2808018A1 (en) | 2014-12-03 |
| KR20140134266A (ko) | 2014-11-21 |
| EP2808018B1 (en) | 2018-03-14 |
| US20150005506A1 (en) | 2015-01-01 |
| AR089812A1 (es) | 2014-09-17 |
| EP2808018A4 (en) | 2015-07-15 |
| BR112014017902A2 (pt) | 2017-08-22 |
| CN104066430A (zh) | 2014-09-24 |
| CA2862602A1 (en) | 2013-08-01 |
| RU2014134845A (ru) | 2016-03-20 |
| IN2014DN05972A (show.php) | 2015-06-26 |
| JPWO2013111870A1 (ja) | 2015-05-11 |
| JP5924699B2 (ja) | 2016-05-25 |
| HK1201209A1 (en) | 2015-08-28 |
| MX2014008484A (es) | 2014-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW201334779A (zh) | 糖尿病的治療藥 | |
| CN104981242A (zh) | 肿瘤溶解综合征的治疗药和预防药 | |
| UA115647C2 (uk) | Застосування аналога тестостерону і агоніста 5-нт1а для лікування сексуальної дисфункції | |
| CN102223882B (zh) | 用于治疗肥厚型心肌病的III 型磷酸二酯酶(PPE III)抑制剂或Ca2+敏化剂 | |
| US11497748B2 (en) | Method for activating AMPK and the use of adenine | |
| JP2016529307A (ja) | アルツハイマー病の処置に使用するためのｈ３受容体アンタゴニスト | |
| JP6499634B2 (ja) | 過活動膀胱の治療のためのソリフェナシンと唾液分泌刺激剤の組合せ | |
| TWI777059B (zh) | 肌肉減少症之預防劑及治療劑 | |
| JP7357380B2 (ja) | 肥満関連代謝疾患の改善剤 | |
| JP2004244409A (ja) | 糖尿病の発症予防薬 | |
| JPWO2007007757A1 (ja) | ＰＰＡＲγアゴニストを含有する医薬組成物 | |
| JP2014513689A (ja) | 過活動膀胱の治療のためのトロスピウムと唾液分泌刺激剤の組合せ | |
| US20100324081A1 (en) | Preventive, inhibitor or remedy for cerebral aneurysm comprising ibudilast as an active ingredient | |
| JP2020143037A (ja) | 糖尿病合併心不全の治療用医薬組成物 | |
| KR20100017460A (ko) | 피피에이알 감마 작용물질로 인한 부작용의 예방에 유용한 조성물 | |
| JPWO2001013911A1 (ja) | 高血圧性細動脈障害抑制剤 | |
| TW202547551A (zh) | 降低血脂之組合物及其用途 | |
| WO2010098475A1 (ja) | 摂食障害予防及び治療剤 | |
| WO2023014748A1 (en) | Nitrated fatty acids for the treatment of sickle cell disorders | |
| WO2007123126A1 (ja) | 慢性心不全における運動耐容能低下の改善剤 | |
| WO2015046857A1 (ko) | 자가면역성 갑상선 질환의 예방 또는 치료용 조성물 | |
| JP2007530643A (ja) | 複素環化合物と抗酸化剤との組合わせ、および肥満症を処置するためのその使用 | |
| JP2008179574A (ja) | ピペラジン誘導体を有効成分とする糖化最終産物形成阻害剤 | |
| JP2008273859A (ja) | 腎機能障害を持つ心不全患者を治療するためのコハク酸シベンゾリンを有効成分とする不整脈治療剤 | |
| JPWO2019225722A1 (ja) | 代謝改善剤 |